Skip to main content

Ethicon Physiomesh Bellwether Trial Schedule Released

Ethicon Physiomesh Bellwether Trial Schedule Released

Ethicon Physiomesh Bellwether Trial Schedule Released

Introduction

In an Amended Practice and Procedure Order issued on January 17, 2019, Judge Richard Story announced a scheduling order for the preparation of cases for the first Ethicon hernia mesh bellwether trials scheduled to begin on February 3, 2020.

As per the amended order, the parties are allowed to choose 10 cases by April this year from an initial discovery pool containing 24 cases, which were picked last year. For expert discovery process, each side must pick 5 trial pool cases. By July 1, 2019, plaintiffs are required to submit expert disclosures and reports, and defendants can submit them by August 2. Selection for all trial pool cases is to be completed by October 14, 2019, along with dispositive or Daubert motions by October 28, 2019. Responses to those motions are to be filed by November 15 for which replies are expected by November 25. The outcome for the tests trials would help parties gauge the relative merits and demerits of the cases.

There are about 1,700 Ethicon Physiomesh lawsuits pending in the U.S. federal courts, each with claims that the flexible composite hernia mesh was prone to wear and tear and caused severe complications among several patients due to design defects. Ethicon Physiomesh Multi-District Litigation (MDL No. 2782; In Re: Ethicon Physiomesh Flexible composite Hernia Mesh Products Liability Litigation) is overlooked by U.S. District Judge Richard Story in the Northern District of Georgia for consolidated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!